Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany

समान संसाधन

• High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
  द्वारा: Schultz, Philipp, और अन्य
  प्रकाशित: (2021)
• Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
  द्वारा: Hawchar, Fatime, और अन्य
  प्रकाशित: (2022)
• Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
  द्वारा: Köhler, Thomas, और अन्य
  प्रकाशित: (2022)
• Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
  द्वारा: Köhler, Thomas, और अन्य
  प्रकाशित: (2021)
• The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
  द्वारा: Unterberg, Matthias, और अन्य
  प्रकाशित: (2022)